Related Experiment Video
Updated: Aug 31, 2025

Phenotypic Characterization of Macrophages from Rat Kidney by Flow Cytometry
Published on: October 18, 2016
LNA-anti-miR-150 alleviates renal interstitial fibrosis by reducing pro-inflammatory M1/M2 macrophage polarization
Xiangnan Hao1, Junjun Luan1, Congcong Jiao1
1Department of Nephrology, Shengjing Hospital of China Medical University, Shenyang, China.
Abstract:
Renal interstitial fibrosis (RIF) is a common pathological feature contributing to chronic injury and maladaptive repair following acute kidney injury. Currently, there is no effective therapy for RIF. We have reported that locked nuclear acid (LNA)-anti-miR-150 antagonizes pro-fibrotic pathways in human renal tubular cells by regulating the suppressor of cytokine signal 1 (SOCS1)/Janus kinase (JAK)/signal transducer and activator of transcription (STAT) pathway. In the present study, we aimed to clarify whether LNA-anti-miR-150 attenuates folic acid-induced RIF mice by regulating this pathway and by reducing pro-inflammatory M1/M2 macrophage polarization. We found that renal miR-150 was upregulated in folic acid-induced RIF mice at day 30 after injection. LNA-anti-miR-150 alleviated the degree of RIF, as shown by periodic acid-Schiff and Masson staining and by the expression of pro-fibrotic proteins, including alpha-smooth muscle actin and fibronectin. In RIF mice, SOCS1 was downregulated, and p-JAK1 and p-STAT1 were upregulated. LNA-anti-miR-150 reversed the changes in renal SOCS1, p-JAK1, and p-STAT1 expression. In addition, renal infiltration of total macrophages, pro-inflammatory M1 and M2 macrophages as well as their secreted cytokines were increased in RIF mice compared to control mice. Importantly, in folic acid-induced RIF mice, LNA-anti-miR-150 attenuated the renal infiltration of total macrophages and pro-inflammatory subsets, including M1 macrophages expressing CD11c and M2 macrophages expressing CD206. We conclude that the anti-renal fibrotic role of LNA-anti-miR-150 in folic acid-induced RIF mice may be mediated by reducing pro-inflammatory M1 and M2 macrophage polarization via the SOCS1/JAK1/STAT1 pathway.
Insights
Locked nucleic acid-anti-miR-150 therapy reduces renal interstitial fibrosis in mice. This treatment targets the SOCS1/JAK/STAT pathway and decreases pro-inflammatory macrophage polarization, offering a potential therapeutic strategy for kidney fibrosis.
Area of Science:
- Nephrology
- Molecular Biology
- Immunology
Background:
- Renal interstitial fibrosis (RIF) is a common outcome of acute kidney injury with no effective treatments.
- Locked nucleic acid-anti-miR-150 (LNA-anti-miR-150) has shown potential in antagonizing pro-fibrotic pathways in renal cells.
- The SOCS1/JAK/STAT pathway and macrophage polarization are implicated in kidney fibrosis progression.
Purpose of the Study:
- To investigate if LNA-anti-miR-150 can attenuate folic acid-induced RIF in mice.
- To determine if LNA-anti-miR-150 regulates the SOCS1/JAK/STAT pathway in RIF.
- To assess the effect of LNA-anti-miR-150 on M1/M2 macrophage polarization in RIF.
Main Methods:
- Induction of RIF in mice using folic acid.
- Administration of LNA-anti-miR-150 to RIF mice.
- Histopathological analysis (PAS and Masson staining) for fibrosis.
- Assessment of pro-fibrotic protein expression (alpha-smooth muscle actin, fibronectin).
- Evaluation of SOCS1, p-JAK1, and p-STAT1 expression.
- Analysis of macrophage infiltration (CD11c, CD206) and cytokine levels.
Main Results:
- Folic acid-induced RIF mice showed increased miR-150, fibrosis, SOCS1 downregulation, and p-JAK1/p-STAT1 upregulation.
- LNA-anti-miR-150 treatment alleviated RIF and reversed the molecular changes in the SOCS1/JAK/STAT pathway.
- RIF mice exhibited increased macrophage infiltration (M1 and M2) and cytokine levels, which were attenuated by LNA-anti-miR-150.
Conclusions:
- LNA-anti-miR-150 effectively alleviates renal interstitial fibrosis in a mouse model.
- The therapeutic effect is associated with the regulation of the SOCS1/JAK/STAT pathway.
- LNA-anti-miR-150 reduces pro-inflammatory M1 and M2 macrophage polarization, suggesting a novel therapeutic mechanism for RIF.

